(Fig. 2a) After injection, held-up IL-2 fusion protein toggles between four states within the tumor: unbound, bound to collagen, bound to IL-2 receptor (IL-2R), or concurrently bound to both targets (Fig. 2b). The gene discussed is IL2; the disease is neoplasm.